DR-05 TREATMENT AND PROGNOSIS AFTER BEVACIZUMAB FAILURE IN RECURRENT GLIOBLASTOMA: THE CLEVELAND CLINIC EXPERIENCE

Por Sakruti, Susmita, Vyshak, Alva, Griffith, Sandra, Stevens, Glen, Peereboom, David, Ahluwalia, Manmeet
Publicado em 2014

Validation Study: Response-Predictive Gene Expression Profiling of Glioma Progenitor Cells In Vitro

Por Moeckel, Sylvia, Vollmann-Zwerenz, Arabel, Proescholdt, Martin, Brawanski, Alexander, Riemenschneider, Markus J., Bogdahn, Ulrich, Bosserhoff, Anja-Katrin, Spang, Rainer, Hau, Peter
Publicado no PLoS One (2016)

Outcome of patients with glioblastoma in Saudi Arabia: Single center experience

Por ALTWAIRGI, ABDULLAH K., ALGAREEB, WALEED, YAHYA, GAAEM, MAKLAD, AHMED M., ALY, MOAMEN MOM, AL SHAKWEER, WAFA, BALBAID, ALI, ALSAEED, EYAD, ALHUSSAIN, HUSSAIN, ORZ, YASSIR, LARY, AHMED, ELYAMANY, ASHRAF
Publicado no Mol Clin Oncol (2016)

ACTR-41. INTERIM RESULTS OF FIRST-IN-HUMAN STUDY USING NATIVIS VOYAGER™ SYSTEM IN PATIENTS WITH RECURRENT GLIOBLASTOMA (GBM)

Por Barkhoudarian, Garni, Cobbs, Charles, McClay, Edward, Vaillant, Brian, Duic, J Paul, Nabors, Burt, Ellingson, Benjamin, Sheffield, Deborah, Kesari, Santosh
Publicado no Neuro Oncol (2017)

RBTT-08. EORTC 1709/CCTG CE.8: A PHASE III TRIAL OF MARIZOMIB IN COMBINATION WITH STANDARD TEMOZOLOMIDE-BASED RADIOCHEMOTHERAPY VERSUS STANDARD TEMOZOLOMIDE-BASED RADIOCHEMOTHERAPY...

Por Roth, Patrick, Reijneveld, Jaap, Gorlia, Thierry, Dhermain, Frederic, Vanlancker, Maureen, Fournier, Beatrice, Nuyens, Sarah, O’Callaghan, Chris, Le Rhun, Emilie, Elias, Ileana, van den Bent, Martin, Mason, Warren, Winograd, Benjamin, Weller, Michael
Publicado no Neuro Oncol (2018)

Survival effect of first- and second-line treatments for patients with primary glioblastoma: a cohort study from a prospective registry, 1997–2010

Por Nava, Francesca, Tramacere, Irene, Fittipaldo, Andrea, Bruzzone, Maria Grazia, DiMeco, Francesco, Fariselli, Laura, Finocchiaro, Gaetano, Pollo, Bianca, Salmaggi, Andrea, Silvani, Antonio, Farinotti, Mariangela, Filippini, Graziella
Publicado em 2014

P13.03 HYPOFRACTIONATED STEREOTACTIC RADIOTHERAPY (HSR) IN RECURRENT HIGH GRADE GLIOMA: A SAFE AND EFFECTIVE APPROACH

Por Ascolese, A., Pessina, F., Navarria, P., Tomatis, S., Mancosu, P., Clerici, E., Bello, L., Lobefalo, F., Grimaldi, M., Scorsetti, M.
Publicado em 2014

Cyclopamine cooperates with EGFR inhibition to deplete stem-like cancer cells in glioblastoma-derived spheroid cultures

Por Eimer, Sandrine, Dugay, Frédéric, Airiau, Kelly, Avril, Tony, Quillien, Véronique, Belaud-Rotureau, Marc-Antoine, Belloc, Francis
Publicado em 2012

P17.76 LOW-DOSE RATE STEREOTACTIC IODINE-125 BRACHYTHERAPY FOR THE TREATMENT OF INOPERABLE PRIMARY AND RECURRENT GLIOBLASTOMA: SINGLE-CENTER EXPERIENCE WITH 201 CASES

Por Kickingereder, P., Hamisch, C., Suchorska, B., Galldiks, N., Visser-Vandewalle, V., Goldbrunner, R., Kocher, M., Treuer, H., Voges, J., Ruge, M.I.
Publicado em 2014

IT-11 A PHASE I/ II CLINICAL TRIAL OF CT-011 (PIDILIZUMAB) IN DIFFUSE INTRINSIC PONTINE GLIOMA AND RELAPSED HIGH GRADE GLIOMA: A PRELIMINARY REPORT

Por Fried, Iris, Weintraub, Michael, Ben Ami, Tal, Shen, Roy, Benifla, Mony, Mordechai, Anat, Lossos, Alex
Publicado em 2014

Skeletal metastasis in renal cell carcinoma: A review

Por Umer, Masood, Mohib, Yasir, Atif, Muhammed, Nazim, Muhammad
Publicado no Ann Med Surg (Lond) (2018)

EAPH-08. A PHASE I TRIAL OF TTFIELDS WITH AND WITHOUT CONCOMITANT TEMOZOLOMIDE AND BEVACIZUMAB IN PEDIATRIC PATIENTS WITH HIGH-GRADE GLIOMA

Por Hanson, Derek
Publicado no Neuro Oncol (2018)

Pituitary adenylyl cyclase activating polypeptide inhibits gli1 gene expression and proliferation in primary medulloblastoma derived tumorsphere cultures

Por Cohen, Joseph R, Resnick, Daniel Z, Niewiadomski, Pawel, Dong, Hongmei, Liau, Linda M, Waschek, James A
Publicado em 2010

P17.80 ANAPLASTIC GLIOMA: AN UPDATE ON TREATMENT STRATEGIES

Por Simonetti, G., Gaviani, P., Innocenti, A., Botturi, A., Lamperti, E., Silvani, A.
Publicado em 2014

Safety and efficacy of sunitinib in patients from Latin America: subanalysis of an expanded access trial in metastatic renal cell carcinoma

Por Barrios, Carlos H, Herchenhorn, Daniel, Chacón, Matías, Cabrera-Galeana, Paula, Sajben, Peter, Zhang, Ke
Publicado no Onco Targets Ther (2016)

Surgical strategy for temporal lobe epilepsy with dual pathology and incomplete evidence from EEG and neuroimaging

Por Luan, Lan, Sun, Yuqiang, Yang, Kang
Publicado no Exp Ther Med (2018)

SUN-420 Pituitary Apoplexy Associated With Apixaban

Por Fanous, Nada, Srihari, Ashok, Roper, Steven, Woodmansee, Whitney
Publicado no J Endocr Soc (2019)

Organ microcirculation a gateway to diagnostic and therapeutic interventions /

Por Ishii, Hiromasa., Keio International Symposium for Life Sciences and Medicine
Publicado em 2005

ET-53 IPILIMUMAB FOR RECURRENT GLIOBLASTOMA (GBM)

Por Schaff, Lauren R., Lassman, Andrew B., Goldlust, Samuel A., Cloughesy, Timothy, Singer, Samuel, Schwartz, Gary K., Iwamoto, Fabio M.
Publicado em 2014

Differential Response of Immunohistochemically Defined Breast Cancer Subtypes to Anthracycline-Based Adjuvant Chemotherapy with or without Paclitaxel

Por Fountzilas, George, Dafni, Urania, Bobos, Mattheos, Batistatou, Anna, Kotoula, Vassiliki, Trihia, Helen, Malamou-Mitsi, Vassiliki, Miliaras, Spyros, Chrisafi, Sofia, Papadopoulos, Savvas, Sotiropoulou, Maria, Filippidis, Theodoros, Gogas, Helen, Koletsa, Triantafyllia, Bafaloukos, Dimitrios, Televantou, Despina, Kalogeras, Konstantine T., Pectasides, Dimitrios, Skarlos, Dimosthenis V., Koutras, Angelos, Dimopoulos, Meletios A.
Publicado em 2012